Final answer:
In clinical trials for psychiatric conditions, patients are not always given the experimental drug; a control group usually receives a placebo to provide a comparison, and trials are often double-blind to prevent bias.
Step-by-step explanation:
The statement that in clinical trials designed to test new treatments for psychiatric conditions, patients with the disorder are always given the experimental drug is false. Clinical trials typically utilize a control group that receives a placebo rather than the experimental drug in order to establish a baseline for comparison with the experimental group that is receiving the actual drug. This approach is essential in determining the efficacy of the new treatment while eliminating the placebo effect and other biases. Clinical trials often employ a double-blind method, where neither the participants nor the researchers know who has received the experimental drug and who has received the placebo.